Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial by Cathrine Lund Lorentzen, Evelina Martinenaite, Evelina Martinenaite, Julie Westerlin Kjeldsen, Rikke Boedker Holmstroem, Sofie Kirial Mørk, Ayako Wakatsuki Pedersen, Eva Ehrnrooth, Mads Hald Andersen, Inge Marie Svane

Get full text

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types by Marco Donia, Troels Holz Borch, Özcan Met, Julie Westerlin Kjeldsen, Morten Nielsen, Inge Marie Svane, Anders Handrup Kverneland, Christopher Aled Chamberlain, Sofie Kirial Mørk, Cathrine Lund Lorentzen, Lise Pyndt Jørgensen, Lene Buhl Riis, Christina Westmose Yde

Get full text

First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer by Sofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, Benedetta Albieri, Joachim Stoltenborg Granhøj, Marco Donia, Evelina Martinenaite, Evelina Martinenaite, Morten Orebo Holmström, Morten Orebo Holmström, Kasper Madsen, Anders H. Kverneland, Julie Westerlin Kjeldsen, Rikke Boedker Holmstroem, Cathrine Lund Lorentzen, Nis Nørgaard, Lars Vibe Andreasen, Grith Krøyer Wood, Dennis Christensen, Michael Schantz Klausen, Sine Reker Hadrup, Per thor Straten, Per thor Straten, Mads Hald Andersen, Mads Hald Andersen, Inge Marie Svane

Get full text